09:48 AM EST - Theralase Technologies Inc. : announced today that it has presented its latest research on the success of its Photo Dynamic Compounds in the destruction of cancer and bacteria. This research was presented at the 10th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, taking place in Brixen, Italy from October 14 to 18. Theralase Technologies Inc.
shares V.TLT are trading up $0.025 at $0.29.
